Annual report pursuant to Section 13 and 15(d)

Stock Options and Restricted Stock Units (Details Narrative)

v3.21.1
Stock Options and Restricted Stock Units (Details Narrative) - USD ($)
 12 Months Ended
Jan. 06, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2017
Dec. 31, 2016
Number of options issued   128,000      
Options fully vested exercise price   $ 0.50      
Exercise price per share   $ 0.50      
Estimated expected term   5 years      
Options grants in period, value   $ 18,023      
Stock-based compensation   24,327    
Option Repricing [Member]          
Number of options issued 252,440        
Exercise price per share $ 2.50        
Stock options outstanding percentage 54.00%        
Stock option expense   $ 6,304      
Independent Directors One [Member]          
Number of options issued   40,000      
Options fully vested exercise price   $ 0.50      
Independent Directors Two [Member]          
Number of options issued   40,000      
Options fully vested exercise price   $ 0.50      
One Other Independent Directors [Member]          
Number of options issued   20,000      
Options fully vested exercise price   $ 0.50      
Board Observer [Member]          
Number of options issued   20,000      
Options fully vested exercise price   $ 0.50      
Expiration period   10 years      
New Directors [Member]          
Number of options issued   8,000      
Options fully vested exercise price   $ 0.50      
Expiration period   5 years      
Stock options vesting, description   The 8,000 options to the new director vest half in 12 months and the balance in 24 months.      
Vested period   1 year      
2016 Omnibus Equity Incentive Plan [Member]          
Number of shares authorized for grant         160,000
2016 Omnibus Equity Incentive Plan [Member] | Board Resolution and Amendment in 2017 [Member]          
Number of shares authorized for grant       400,000